Editorial: Herbal medicines in women's lives.

Su SY
Frontiers in pharmacology · 2022 · doi:10.3389/fphar.2022.1003241 · PMID:36467055 · PMC9709691
OA: gold CC-BY-4.0
📄 Open PDF Full text JSON View on PubMed View at publisher
⚙ AI-generated summary by qwen3.7-flash+body, 2026-08-14 ⓘ

This editorial discusses herbal medicines in women's lives, authored by S-YS without commercial conflicts or financial relationships.

One-sentence paraphrase of the abstract; not a substitute for reading it. No clinical advice. How this works

⚙ AI-generated deep summary by qwen3.7-flash, 2026-08-14 · read from full text ⓘ

This editorial piece outlines the general scope of herbal medicine usage within women's health contexts without presenting original empirical data or specific clinical trial results. The text serves as an introductory commentary, acknowledging the broad application of botanical remedies in managing various aspects of female physiology and well-being. It emphasizes the need for rigorous evaluation of these traditional treatments while noting the author’s declaration of no commercial conflicts of interest. Relevance to endometriosis: listed as one indication for GnRH antagonists, though the paper's main focus is uterine fibroids.

Read from the paper's body, not the abstract. Not a substitute for reading the paper. No clinical advice. How this works

Full text 548 characters · extracted from epmc-fulltextxml · 3 sections · click to expand

Author

S-YS wrote the manuscript.

Conflict

The author declares that the research was conducted in the absence of any commercial or financial relationships that could be construed as a potential conflict of interest.

Publisher’S

All claims expressed in this article are solely those of the authors and do not necessarily represent those of their affiliated organizations, or those of the publisher, the editors and the reviewers. Any product that may be evaluated in this article, or claim that may be made by its manufacturer, is not guaranteed or endorsed by the publisher.

Text is read by the "Ask this paper" AI Q&A widget below. Extraction quality varies by source — PMC NXML preserves structure cleanly, OA-HTML may include some navigation residue, and OA-PDF can have broken hyphenation. The publisher copy (via DOI) is the canonical version.

My notes (saved in your browser only)

⚙ Ask this paper AI returns verbatim quotes from the full text · source: epmc-fulltextxml ⓘ

Answers must be backed by verbatim quotes from this paper's full text. Hallucinated quotes are dropped automatically; if no verbatim passage answers the question, we say so. How this works

Citation neighborhood (no data yet)

We don't have any in-corpus citations linked to this paper yet. The paper's references may be in our DB but unresolved to ``paper_id`` (resolution happens at ingest when the cited DOI matches a row we already have). Run the cross-source citation reconcile pass to retry.

Source provenance

europepmc
last seen: 2026-09-06T09:34:12.023084+00:00
License: CC-BY-4.0 · commercial use OK · attribution required
Per Europe PMC